BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6759741)

  • 1. [Effect of a PGI2 derivative (op-41483) during extracorporeal circulation].
    Matsukura H; Takeda H; Edasawa H; Sakai K; Kawakami T
    Kyobu Geka; 1982 Nov; 35(11):876-7. PubMed ID: 6759741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of PGI2 during extracorporeal circulation].
    Matsukura H; Takeda H; Kawakami T; Kuroshima S; Tanabe T
    Kyobu Geka; 1981 Feb; 34(2):113. PubMed ID: 7026851
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep.
    Uziel L; Agostoni A; Pirovano E; Pesenti A; Pelizzola A; Gattinoni L; Galmarini D
    Int J Artif Organs; 1981 May; 4(3):142-5. PubMed ID: 7024139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
    Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
    Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
    Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).
    Orchard MA; Ritter JM; Shepherd GL; Lewis PJ
    Br J Clin Pharmacol; 1983 May; 15(5):509-11. PubMed ID: 6344895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of prostaglandin I2 and its derivative in extracorporeal circulation].
    Takeda H; Matsukura H; Kawakami T; Tanabe T
    Kyobu Geka; 1983 Jun; 36(6):479-84. PubMed ID: 6355587
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 10. Epoprostenol now the focus of numerous clinical trials.
    Check WA
    JAMA; 1981 Jun; 245(24):2481-3. PubMed ID: 7014954
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
    Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
    Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of prostaglandin I2 derivative infusion during experimental cardiopulmonary bypass].
    Matsukura H; Takeda H; Uzawa S; Sakai K; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Jun; 31(6):871-5. PubMed ID: 6352833
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of PGI2 and di-butyryl cyclic-AMP on platelets exposed to shear stress.
    Hardwick RA; Hellums JD; Peterson DM; Moake J; Olson J
    Trans Am Soc Artif Intern Organs; 1981; 27():192-6. PubMed ID: 6277071
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biocompatibility and extracorporeal circulation].
    Camici M
    Clin Ter; 1995 Nov; 146(11):713-9. PubMed ID: 8720347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostacyclin (PGI2) on haematological and haemodynamic parameters, and lung histology in puppies undergoing cardiopulmonary bypass surgery with profound hypothermia.
    Starling MB; Neutze JM; Hill DG; Jagusch M; Cleland JF; Johns A; Elliott RL
    Prostaglandins Leukot Med; 1985 Jan; 17(1):11-29. PubMed ID: 3883367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
    Dusting GJ; Vane JR
    Circ Res; 1980 Jun; 46(6 Pt 2):I183-7. PubMed ID: 6991150
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of prostaglandin I2 infusion during experimental cardiopulmonary bypass (author's transl)].
    Matsukura H; Takeda H; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Feb; 30(2):164-71. PubMed ID: 7047654
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin and anti-platelet drugs.
    J Assoc Physicians India; 1979 Feb; 27(2):149-51. PubMed ID: 389924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.